The complexity of opioid use disorder (OUD) makes it difficult to treat, including for device designers looking to help tackle what the US Food and Drug Administration calls a “national crisis.”
To facilitate innovation in the development of devices to treat OUD, the FDA recently published draft guidance to help sponsors design clinical trials to evaluate these devices.